The ribonucleotide reductase (RR) 2 gene of the HSV-2 strain G was cloned, sequenced, and expressed in an E. coli cell. The RR2 gene was located on the PstI 2.4 kb fragment, which was cloned and sequenced. The ORF of the gene was 1,011 bp and its termination codon was TAG; also, the CATATAA sequence was present in the promoter of the RR2 gene. A Poly A signal sequence (AATAAA) was found in the 3'-noncoding region. The RR2 proteins that were produced in the E. coli and Vero cells were confirmed using a Western blot analysis. SDS-PAGE revealed that the molecular weights of the fusion-RR2 that was produced in the E. coli cells were approximately 24 kDa and 38 kDa in the Vero cells. The RR2 proteins were soluble. The differences in the molecular weights might be due to modifications in the Vero cells.
Introduction
Herpes simplex virus (HSV) ribonucleotide reductase (RR) is a delayed, early (DE) protein (Langelier et al., 1978) . It is associated with the arrest and incompatibility in regard to the induction of gene amplification and long-term cell survival (Becker and Sarov, 1968; Langelier et al., 1978) . These enzymes consist of RR1 and RR2 subunits (Duita, 1983) ; RR1 with a molecular weight of 140 kDa and RR2 with a molecular weight of 38 kDa, as reported by several investigators (Galloway and McDougall, 1981; Bachetti et al., 1986; Wymer et al., 1989) . The nucleotide sequences of the RR gene of the HSV-2 strain 333 (Galloway and Swain, 1984) and HSV-1 (Draper et al., 1982) were determined and analyzed. However, they did not perform the genes expression in the E. coli cells as well as they did the sequencing of other strains. Therefore, we cloned and expressed the gene of the HSV-2 strain G, which is a mild pathogen for humans. The aims of this study were to clone, sequence, and express the RR2 gene of the HSV-2 strain G in a prokaryotic cell.
Materials and Methods
Viruses, bacterial strains, cells, and plasmids The HSV-2 strain G (ATCC VR-734) was obtained from the Korean AIDS Center, Seoul, Korea. Vero cell lines (ATCC-CCL 81) were obtained from the Korean Type Culture Collection (KTCC), Seoul, Korea. The Vero cells were grown in an Eagles minimum essential medium (MEM) (Gibco, Detroit, USA) that contained 10% fetal bovine serum (Gibco) 
Oligonucleotides and restriction mapping One oligonucleotide probe (5'-CGCGATCGCCTGCTGGGCC-3') was deduced from the terminal sequences of the published sequences of the RR1 gene of HSV-1 (Draper et al., 1982) and synthesized by Korea Biotech Inc. (Daejeon, Korea). All of the restriction endonuclease digestions were performed according to the manufacturers instructions.
The physical restriction map of the PstI fragment was constructed with seven enzymes (DraII, BamHI, SacI, PvuII, BstEII, EcoRV, and HincII) . The digested DNA fragments were electrophoresed on a 0.6% agarose gel (Sambrook et al., 1989; Lee et al., 1998; Ju et al., 2001; Uh et al., 2001) .
Preparation of plasmid DNAs and agarose gel electrophoresis E. coli that contained the recombinant plasmids was cultured in a LB broth that contained the proper antibiotics at 37 o C. The plasmid DNA was purified according to the procedure that was described by Birnboim and Doly (1979) and Hwang et al., (1998) . A rapid, small-scale plasmid analysis was performed using microcentrifugation at 15,000 rpm for 1 min. The purified DNAs were then examined by 0.8% agarose gel electrophoresis (Sambrook et al., 1989) . µJPO RI ampicillin, 2% X-gal (5-bromo-4-chloro-3-indol-β-galactoside), and 100 mM IPTG (isopropyl-β-D-thio-galactopyranoside) (Sigma).
Molecular cloning

Determination of the nucleotide sequence
The DNA fragment that contained the RR2 gene was digested with restriction enzymes (BstEII, EcoRV, SacI, PstI, and XhoI) using the procedure that was described by Lee et al., (1998) . The DNA fragment was inserted in pBluescript SK(+) and sequenced by the procedure that was described by Sanger et al., (1977) . 
Purification of MBP-RR2 fusion proteins
Preparation of polyclonal antiserum
The fusion proteins (0.5 g) were mixed with an equal volume of complete Freunds adjuvant (Gibco) and injected into the peritoneal cavity of a mouse. After 3 weeks, 0.5 g of the antigen and an equal volume of incomplete Freund's adjuvant (Gibco) were also mixed and injected into the peritoneal cavity. To obtain an antiserum, the fluid was collected from the heart after 10-14 d, incubated at 4 o C for 18 h, centrifuged at 2,700 × g for 10 min, and then the resultant supernatant was stocked at −20 o C. 
SDS-PAGE and
Results and Discussion
Cloning and nucleotide sequence analysis of the RR2 gene To clone and obtain the complete nucleotide sequence of the DNA fragment that encodes the RR2 gene of the HSV-2 strain G, we digested the HSV-2 genomic DNAs with the BglII enzyme. It was then cleaved into 15 fragments that ranged from 1.2 −16.92 kb (1.2, 1.9, 3.34, 3.52, 4.3, 4.43, 6.4, 7.1, 8.05, 8.32, 9.34, 11.2, 14, 15.9, 16 .92 in kb) (Fig. 2, lane 2) on 0.6% agarose gel. These fragments were cloned into the BglII site of the pBacPAK9 vector (Fig. 1) . Each clone was named pH2Bg-1, 2, −15 according to the lowest order of electrophoretic mobilities in the agarose gel. They were confirmed by redigestion with the enzyme and Southern blot analysis with the BglII HSV-2 DNA fragments (data not shown). Using the probe, the fragment that contained the RR2 gene of HSV-2 was identified on the pH2Bg-8 that contained the 7.1 kb DNA fragment (Fig. 2, lanes 3) . Then the RR2 gene was digested with PstI. The resulting 2.4 kb DNA fragment was subcloned into the PstI site of the pBluescript SK(+) vector. The generated clone was named pHS-RR (5.36 kb) (Fig. 1) . The 2.4 kb DNA fragment was analyzed with seven restriction enzymes, and a physical restriction map of the fragment was constructed (data not shown).
The 2.4 kb RR2 gene fragment was digested with BamHI, PvuII, EcoRV, and DraII. The resulting fragments were cloned into the pBluescript SK (+) vector and sequenced. The nucleotide sequences of the noncoding strand and deduced amino acid sequences of the RR2 gene of the HSV-2 strain G are illustrated in Fig. 3 . A total of 1,711 nucleotides were sequenced; 1014 bases of the open-reading frame, 369 bases 5'-upstream of the ORF, and 328 bases downstream from the termination codon (Fig. 3) . The open-reading frame (ORF) was 1,014 kb from the ATG translation initiation codon to the TGA termination codon (boldfaced), which could encode a 337-amino acid polypeptide (GenBank accession No. AF305570). The G strain had a termination codon, TAG, which was different than the strain 333, where it was TGA (Galloway and Swain, 1984) . Nucleotides at 454 and 904 (shaded) in the ORF of the G strain were different than those with the strain 333. The codons ACC and TCC in the G strain were changed into codons AAC and CCC in the strain 333, respectively (Galloway and Swain, 1984) . These results indicated that the threonine and serine residues in the G strain were changed into asparagine and proline in the strain 333 at the nucleotide 454 and 904 codons ( Table 1 ). The sequence homology between the G and 333 strains appeared to be Fig. 1 . Construction scheme for pHS-RR and pMal-RR plasmids containing the RR2 gene sequence. The 7.1 kb DNA fragment that contained the RR2 gene was cloned into the pBacPAK9 vector. The clone was then redigested with the PstI enzyme to cut out the RR2 gene sequence, which was cloned into the PstI site of the pBluescript SK(+) and named pHS-RR plasmid. The RR2 gene was transferred into the SalI and HindIII sites of the pMal-cRI vector to construct the pMal-RR recombinant plasmid (8.15 kb). The cloning site was partially sequenced.
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99.9%. In the promoter region upstream of the ORF, the CATATAA sequence was located from nucleotides −159 to −165 sites, and was identical in both HSV-1 and HSV-2 (McLaughlan and Clement, 1983; Galloway and Swain, 1984) . The nucleotide sequence of the promoter region of the G strain was almost identical to the HSV-2 strain 333 (Galloway and Swain, 1984) . The sequences that followed the coding region for the RR2 gene of the HSV-2 strain G were almost identical to that of the strain 333 (Galloway and Swain, 1984) . The poly A signal sequence (AATAAA) was found in the 3'-noncoding region, which is located from nucleotides 32 to 38 downstream of the termination codon (Fig. 3) . However, in the strain 333 the sequences were located from nucleotides 35 to 40 (Galloway and Swain, 1984) . The hydrophobility of Putative promoter sequence and 3'-noncoding region of the RR2 gene of HSV-2 appeared. Nucleotide residues are numbered from the 5' to 3' end on the right. The predicted amino acid sequence is displayed under the nucleotide sequence. Amino acid residues are numbered, beginning with the first methionine on the right. The sequence of the noncoding strand is given. The initiation and termination codons are boldfaced. The TATA box in the promoter region is shaded. The polyadenylation signal sequence is underlined. The NT (nucleotide) sequences of the RR2 gene and protein of HSV-2 strain 333 were derived from the report of Galloway and Swain (1984) . Comparisons were made to the strain G nt and deduced amino acid sequences. Base differences at the codons are boldfaced.
the RR2 protein of the HSV-2 strain G was determined by a computer analysis (data not shown). Most amino acid residues were hydrophobic, and a few amino acid residues were hydrophilic. The RR2 protein was composed of 155 non-polar amino acids and 182 polar amino acids.
RR2 protein expression
The expression clone, pMal-RR, was constructed for the RR2 protein expression in E. coli (Fig.  1) . The RR2 gene in the pHS-RR plasmid was transferred into the SalI and HindIII sites of the pMal-cRI vector. The generated clone was named the pMal-RR recombinant plasmid (8.15 kb) (Fig. 1) . The malE gene in the pMal-cRI plasmid is located downstream of the powerful tac promoter, and the fusion of the male protein (MBP) to the RR2 protein may facilitate the purification of the RR2 protein. The ligated site of the SalI site was partially sequenced to confirm the correct cloning of the RR2 gene, which was downstream of the promoter direction (Fig. 1) . The partial sequence indicated that the RR2 gene sequence was correctly cloned downstream of the promoter. The IPTG-induced E. coli with the pMal-RR plasmid produced MBP-RR2 fusion proteins, which were fractionated using an amylose affinity chromatography and measured at 280 nm (data not shown). The production of the RR2 proteins in the Vero cells that were infected with the HSV-2 was detected by 10% SDS-PAGE (Fig. 5) . The RR2 protein appeared to be approximately 38 kDa on the gel (Fig. 5, lane 2) , a finding that was later confirmed by a Western blot analysis (Fig. 5,  lane 2' ). This indicated that the antiserum, which was provided with the fusion proteins (MBP-RR2), indirectly confirmed the production of RR2 proteins by E. coli. The molecular weight differences of the RR2 proteins that were produced in the E. coli system and Vero cells may be caused by the modification process in the cells. This result indicates that the eukaryotic proteins are stably modified in eukaryotic cells.
The cloning, sequencing, and expression in E. coli of RR-2 of the HSV-2 strain G were investigated. This information will provide a basis for a greater understanding of the molecular biology of the RR2 gene and enzyme. The cells were then collected, lysated, and run on SDS-PAGE. The gel was analyzed using Western blot with antiserum against the fusion protein to confirm the antigen of RR2 in the infected cells. There was a hybrid band at the same site with a molecular weight of approximately 38 kDa of the RR2 that was produced by the HSV-2 infection. Lane 1, standard molecular weight markers; Lane 2, cell lysates infected with HSV-2; 2', Western blot of the lane 2 with poly-antiserum against the MBP-RR proteins. Numbers at the left correspond to the positions of the molecular weight markers (in kDa), which are described in Fig. 4 .
